HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of increasing doses of samarium-153-ethylenediaminetetramethylene phosphonate on axial and appendicular skeletal growth in juvenile rabbits.

AbstractINTRODUCTION:
Targeted radiotherapy using samarium-153-ethylenediaminetetramethylene phosphonate (153 Sm-EDTMP) is currently under investigation for treatment of osteosarcoma. Osteosarcoma often occurs in children, and previous studies on a juvenile rabbit model demonstrated that clinically significant damage to developing physeal cartilage may occur as a result of systemic 153 Sm-EDTMP therapy. The aim of this study was to evaluate the late effects of 153 Sm-EDTMP on skeletal structures during growth to maturity and to determine if there is a dose response of 153 Sm-EDTMP on growth of long bones.
METHODS:
Female 8-week-old New Zealand white rabbits were divided into three treatment groups plus controls. Each rabbit was intravenously administered a predetermined dose of 153 Sm-EDTMP. Multiple bones of each rabbit were radiographed every 2 months until physeal closure, with subsequent measurements made to assess for abbreviated bone growth. Statistical analyses were performed to determine the differences in bone length between groups, with significance set at P<.05.
RESULTS:
Significant differences in lengths of multiple bones were detected between the high-dose group and other treatment groups and controls at each time interval. A significant difference in lengths of the tibias was also noted in the medium-treatment group, compared to controls. Mean reduction of bone length was first detected at 4 months and did not increase significantly over time.
CONCLUSIONS:
These data suggest that clinically significant bone shortening may occur as a result of high-dosage administration of 153 Sm-EDTMP. Further investigation regarding the effects of bone-seeking radiopharmaceuticals on bone growth and physeal cartilage is warranted.
AuthorsStephanie C Essman, Michael R Lewis, Derek B Fox
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 35 Issue 2 Pg. 219-25 (Feb 2008) ISSN: 0969-8051 [Print] United States
PMID18312832 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Organophosphonates
  • Radioisotopes
  • Radiopharmaceuticals
  • Samarium
Topics
  • Animals
  • Bone Development (radiation effects)
  • Bone and Bones (diagnostic imaging, radiation effects)
  • Dose-Response Relationship, Radiation
  • Female
  • Growth Plate (diagnostic imaging, radiation effects)
  • Organophosphonates (pharmacokinetics)
  • Rabbits
  • Radioisotopes (adverse effects, pharmacokinetics)
  • Radionuclide Imaging
  • Radiopharmaceuticals (adverse effects, pharmacokinetics)
  • Radiotherapy Dosage
  • Samarium (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: